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Abstrakt 
Vzhledem k širokému spektru účinnosti představují benzodiazepiny (BZs) jedny z 
nejčastěji předepisovaných léčiv. V určitých indikacích jsou podávány i během těhotenství a 
novorozencům či kojencům. Klinické studie však naznačují, že podávání těchto látek v 
časných stadiích vývoje může dlouhodobě ovlivnit chování jedince. V klinické praxi je těžké 
oddělit následky časného podávání BZs od změn spojených s vlastním onemocněním. Jednou 
z možností, jak stanovit rizika podávání těchto látek pro vyvíjející se mozek je použití 
relevantních experimentálních modelů. Úkolem předkládané studie bylo zhodnotit rizika 
podávání clonazepamu (CZP) pro další vývoj funkčních schopností jedince. Mláďatům 
potkana byl podáván CZP v terapeuticky relevantních dávkách (0.1 – 1 mg/kg/den) v průběhu 
pěti dní (od postnatálního dne /P/ 7 do P11) Zvířata byla opakovaně testována s použitím 
baterie behaviorálních testů hodnotících kognitivní funkce, motivaci a emocionalitu od P12 až 
P90. 
Výsledky ukazují, že podávání CZP v testovaných dávkách ve fázi vývoje odpovídající stadiu 
lidského nedonošence až novorozence nevede k porušení paměti a schopnosti učení s 
výjimkou dlouhodobé habituace. Dochází však ke zvýšení lokomoční activity a snížení 
motivace. V období adolescence byla u zvířat, kterým byl CZP podáván, nalezena změna 
sociálního chování. 
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Abstract 
Benzodiazepines (BZs) are widely prescribed because of broad spectrum of therapeutic 
effects. Under specific conditions they can be used during the pregnancy and early postnatally 
in humans. However, clinical studies suggest their possible behavioral teratogenicity even 
though it is difficult to separate consequences of early BZs exposure from underlying 
pathologies in clinical practice. Therefore experimental studies can help us to determine risks 
of early BZs treatment for later development. 
Present study was designed to assess functional consequences of early exposure to 
clonazepam (CZP). Immature rats were exposed to therapeutically relevant doses of CZP (0.1 
– 1 mg/kg/day). CZP was administered for five consecutive day starting at postnatal (P) day 7. 
Behavioral tests started 24 hours after the last CZP injection (i.e. at P12) and continued up to 
the age of 4 months. Battery of behavioral tests evaluating cognitive functions, motivation and 
emotionality was used in this study. 
Present data show that early CZP exposure does not affect memory and learning 
abilities, but it leads to the increase of locomotor activity, decreased motivation and 
impairment of long term habituation. None of these effects was clearly dose-dependent. 
Importantly, early CZP-exposure changed social behavior (social interactions related to play) 
in adolescent rats in dose-dependent manner.  
In conclusion, even relatively short exposure of immature rats to therapeutically relevant 
doses of CZP results in long-lasting functional deficits later in the life. 
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1. Introduction 
Changes of some behavioral parameters represent serious risk of drug administration in 
human infants and children. New drugs are developed in experimental models which use only 
adult animals and even though they are determined for all age groups, tests in developing 
animals are not requested. In mammals, brain development still continues after birth and thus 
developing brain is very prone to effects of exogenous agents. The risk of drug-induced 
functional or developmental alterations is substantially higher when long-lasting treatment is 
necessary and highly effective drugs, interacting with specific targets in the brain are used. 
Antiepileptic drugs represent typical example of this drug category. 
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2. Overview of literature 
 
 
2.1 Benzodiazepines and their usage 
Benzodiazepines (BZs) (Fig.1) were introduced into clinical practice in 1960. 
Chlordiazepoxide (trade name Librium) was first released BZ, followed by introduction of 
famous diazepam (Valium). Since that time, over 50 BZs have been introduced into clinical 
practice. They have become one of the most frequently prescribed psychotrophic drugs. In 
1973, at the period of their greatest popularity, over 87 million BZ prescriptions were filled 
throughout the world. Although the rate of BZs usage is declining, BZs still remain frequently 
prescribed psychotropic medication due to their rapid effect onset, minimal side effects, low 
toxicity, low risk of overdose and large therapeutic index. BZs are prescribed for their 
anxiolytic, hypnotic, sedative, muscle-relaxant and anticonvulsant properties. According to 
their elimination half-life BZs are categorized as either short-, intermediate- or long-acting 
(Buffet-Jerrot and Stewart, 2002; Haefely, 1988).  
 
Fig.1 Core structure of benzodiazepines 
  
BZs, in particular diazepam, have been reported to be among the most widely prescribed 
drugs in pregnancy, with 30 to 40% of all pregnant women being given anxiolytic drugs at 
some stage of pregnancy (McElthatton, 1994). They can be use to treat depression and in 
manic episodes to control agitation (Ebhard-Gran et al., 2005). BZs has been also shown to be 
effective in the managing preeclampsia or eclampsia, which is an acute and life-threatening 
complication in pregnancy (Iqbal et al., 2002), or as an supportive therapy before Caesarean 
delivery (Collis et al., 2002). About 0.5% of all pregnant women suffer from epilepsy and 
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treatment cannot be disconnected during pregnancy or nursing. Physiological, hormonal and 
pharmacokinetic changes in pregnancy may escalate seizure activity and BZs can be use to 
attenuate possible risks of seizures for developing fetus (Nulman et al., 1999). 
BZs belong among the most potent anticonvulsant drugs and they are used in newborns, 
infants (even premature) and children suffering from epilepsy. Epidemiological studies 
suggest that 0.8 - 1% of the world population has epilepsy. The occurrence of epilepsy 
syndromes in children is significantly higher (~4%) than in adults. Many of these syndromes 
start to manifest during early infancy or childhood and they can be potentially dangerous for 
subsequent psychomotor development of children. BZs are at least partially effective in the 
treatment of atonic seizures, myoclonic seizures, atypical absence seizures, tonic seizures, and 
infantile spasms – seizures, which are among the most difficult to control in children. Thus, 
BZs play major role in the managament or seizure suppression in children (Browne and 
Penry, 1973; Farrell, 1986; Riss et al., 2008). 
 
 
2.1.1 Adverse effects of benzodiapine use 
BZs have been shown to have several adverse effects as described in this chapter. 
However, it has to be emphasized that these effects may significantly differ due to used type 
of BZ, dose and duration of treatment.  
Until the 1970s, it was presumed that BZs did not significantly affect cognitive 
functions in humans. Later studies and longer experiences however demonstrated that BZs 
may alter human cognition. In adults, acute BZ administration has been known to produce 
sedation, drowsiness, psychomotor slowing, anterograde amnesia, and difficulties in learning 
(Buffet-Jerrot and Stewart, 2002; Stewart, 2005). Chronic treatment may lead to impaired 
visiuospatial and visuomotor abilities, decreased IQ, motor coordination, psychomotor speed, 
speed of information processes, verbal learning, memory and concentration. Conversely, there 
is evidence that individuals are likely to develop some tolerance to above mentioned adverse 
effects of BZs when administered for several weeks (Otto et al., 2005; Stewart, 2005).  
Drowsiness represents the most common side effects of BZs administration and it is 
reported in 10-40% of patients. The second most common side effect of chronic 
benzodiazepine administration is incoordination, or ataxia, which develop in 5-20% of 
patient. Other common side effects include feeling of dizziness, agitation or irritability, and 
hypotonia. In addition, BZ treatment may result in weight loss (Browne and Penry, 1973). 
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Long-term use of BZs is connected with development of therapeutic tolerance, which 
could be manifested by either loss of efficacy or a need to escalate the dose to maintain 
benefit. Tolerance can be observed for all BZs effects. In the epilepsy treatment, BZs are 
generally considered unsuitable for long-term control of epilepsy because of possible 
development of anticonvulsant tolerance which was reported mainly in animal models (Riss et 
al., 2008), however they are still successfully used to treat some age-related epileptic 
syndromes or epilepsies as well as in epileptic emergencies (status epilepticus). In anxiety 
treatment, clinical data are somehow controversial. Some reports do not show development of 
tolerance whereas others demonstrate development of tolerance to anxiolytic effects (Stevens 
and Pollack, 2005). 
Dependence develops in almost one-third of patients treated with BZs for more than 
four weeks and it is characterized mainly by a withdrawal syndrome with cessation of 
treatment or reduction of dose and it represents one of the most serious adverse effects of BZs 
(Marriott and Tyrer, 1993). Intensity of withdrawal symptoms ranges from mild (e.g. 
insomnia, gastric problems and anxiety) to severe (e.g. seizures and psychosis). Severity of 
withdrawal symptoms is related to used doses of BZs, duration of treatment, and also to 
history of drug abuse or personal pathology. To prevent withdrawal syndrome gradual 
tapering of BZs doses is recommended (O’Brain, 2005 ; Riss et al., 2008). 
When are given to children BZs may cause the same adverse effects observed in adults 
like memory impairment, psychomotor speed decrease, motor coordination and sustained 
attention alterations (Werry and Aman, 1998). 
BZs have been considered as the teratogenic substances, because they cross the 
placentar barrier. In the early 70’s, studies reported that first trimester exposure to BZs in 
utero resulted in the birth of some infants with facial clefts, cardiac malformation, and other 
multiple malformations, but no syndrome or defects. However, data from later studies provide 
no clear evidence of a significant increase either incidence of malformation or of any 
particular type of defect (McElhatton, 1994). As a general rule, exposure to any type of BZ 
during the first three months of pregnancy should be avoided, because the fetus is the most 
vulnerable to toxic effects of drugs during this period of active neurogenenesis (Iqbal et al., 
2002). Exposure to BZs during the late third trimester seems to be associated with risks for 
the fetus/neonate. Some, but not all infants exposed to BZs at this period of prenatal 
development, exhibit either floppy infant syndrome, or marked neonatal withdrawal 
symptomes. Symptoms vary from mild to sedation, hypotonia, and reluctance to suck, to 
apnoeic spells, cyanosis, and impared metabolic responses to cold stress. These symptoms can 
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persist for periods from hours to months after birth (Ebhard-Gran et al., 2005; McElhatton, 
1994). BZs also accumulate in breast milk and may cause drowsiness of suckling infants 
(Kaneko, 1991).  
 
 
2.2 Pharmacology of Benzodiazepines 
   
 
2.2.1 GABAergic neurotransmission  
Effects of BZs are mediated through their interaction with benzodiazepine receptor 
binding site that acts at synapses in which gamma-aminobutyric acid (GABA) is used as 
transmitter (Haefely et al., 1985). 
 
GABA is the main inhibitory neurotransmitter in the brain and it plays an important role 
in regulating neuronal excitability throughout the nervous system (Fig.2). It is synthesized in 
the terminals of GABAergic neurons from glutamate by its decarboxylation catalysed by 
glutamate decarboxylase and stored in the synaptic vesicles of the nerve terminal. When the 
nerve impulse reaches the nerve terminal, GABA is released into the synaptic cleft. 
Afterwards, high affinity GABA transporters located in the presynaptic GABAergic neurons 
as well as surrounding astrocytes uptake and thus inactivate GABA. Subsequently, GABA 
may be metabolized by GABA-transaminase. In neurons, GABA seems to be preferentially 
recycled and reused in neurotransmission (Petroff, 2002; Madsen et al., 2007). 
 
 
 
 
Fig.2 Molecular structure of gamma-aminobutyric acid 
 
GABA released from GABA neurons into the synaptic cleft, interacts with the GABA 
receptors. There exist at least three different kinds of GABA receptors – GABAA, GABAB 
and GABAC 
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2.2.2 GABA receptors 
GABAA receptor is a pentameric anion-selective channel (Fig.3) composed of seven 
subunit families comprising at least 18 subunits (Fig.4). Muscimol is the selective agonist and 
bicuculline is the selective antagonist of GABAA receptors. In mature brain, the binding of 
GABA causes conformational changes of receptor which increases the chloride influx and 
causes hyperpolarization of the postsynaptic membrane (Möhler, 2007; Sieghart, 1992). 
 
 
 
Fig.3 Scheme of GABAergic synapse depicting major elements of signal transduction (taken 
from Möhler 2007) 
 
 
     
  α 1-6   
  β 1-3   
  γ 1-3   
  δ 1   
  ε 1   
  θ 1   
  ρ 1-3   
      
 
Fig.4 GABAA subunit repertoire (adapted from Möhler 2007)  
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There are several binding sites located at the subunits of the GABAA receptor complex. 
The binding site for GABA is located at the interface α and β subunits. The benzodiazepine 
binding site represents another well described modulatory site at GABA receptor; it is 
localized at the interface α and γ2 subunits (Fig.5). Once bound to the BZ binding site, BZs 
act as positive allosteric modulators and lock the GABAA receptor into a conformation where 
the neurotransmitter GABA has much higher affinity. This leads to increase of frequency of 
channel opening and consequently to the hyperpolarization of the membrane (Sigel, 2002). 
Other binding and modulatory sites were found for the barbiturates, neurosteroids, picrotoxins 
and some metal divalent cations (Sieghart, 1992). 
 
 
Fig.5 Subunit arrangement of GABAA receptor subunits. G – GABA binding site, B –
BZs binding site  
 
 GABAB receptor, discovered in 1981, is located either at the presynaptic or 
postsynaptic membrane and is indirectly coupled via G-proteins to potassium channels. When 
potassium channel opens, the neuronal mebrane becomes hyperpolarized. Baclofen is the 
selective agonist and both saclofen and phaclofen represent selective antagonists at these 
bicuculline-insensitive receptors (Bowery, 2006).  
In early 1990s, the GABAC receptor has been discovered. GABAC receptor acts as 
ligand-gated Cl- channel which is not blocked by bicuculline and is resistant to the modulation 
effect of benzodiazepines, barbiturates or neurosteroids (Johnston, 1996). 
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2.2.3 GABAA receptor subtypes 
GABAA receptor functions (channel kinetics, affinity for GABA, rate of desensitation 
etc.) and pharmacological sensitivity is determined by subunit composition (Möhler, 2006). 
Although there are many possible subunit combinations, most receptors appear to be formed 
by α, β and γ subunits in a 2:2:1 stoichiometry (Derry et al., 2004). Receptors can be 
distinguished by their in/sensitivity to diazepam.  
 
Receptors containing the subunits α1, α2, α3 or α5 in combination with any of the β 
subunits and the γ2 subunit are most prevalent in the brain (85-95%). These receptors are 
sensitive to BZ modulation. The major receptor subtype is assembled from the subunits 
α1β2γ2. Only a few brain regions lack this receptor (e.g. reticular nucleus of thalamus or 
granular cell layer of the olfactory bulb) (Möhler, 2006, 2007; Pirker, 2000). 
Receptors containing the α2 or α3 subunits are markedly less abundant. They are highly 
expressed in areas where the α1 subunit is absent or at low levels. The α2 and α3 subunits are 
frequently co-expressed with β3 and γ2 subunits, which are particulary noticeable in 
hippocampapal pyramidal neurons and in cholinergic neurons of the basal forebrain. α2- and 
α3-receptors differ from α1β2γ2 receptor by having a substantially lower displacing potency 
for various ligands (Möhler, 2006, 2007; Pirker, 2000). 
Receptors containing the α5 are of minor abudance in the brain but they are expressed to 
a significant extent in the hippocampus, where they comprise 15-20% of the diazepam-
sensitive GABAA receptor population. This population is mainly co-assembled with β3 and γ2 
subunits. These receptors are pharmocologically differentiated from α1β2γ2, α2β2γ2 and 
α3β2γ2 receptors by lower affinity to certain substances (Möhler, 2006, 2007; Pirker, 2000). 
GABAA receptors containing α4 and α6 subunits are characterised by insensitivity to 
clinically used BZs such as diazepam, flunitrazepam, clonazepam, and zolpidem and by low 
abudance in the brain. Receptors with α4 subunit are generally expressed at very low 
abudance but more prominently in thalamus and dentate gyrus. Receptors containing α6 
subunit are found in the granular cell layer of the cerebellum. Both receptor populations are 
structurally very heterogenous. The δ subunit is frequently co-assembled with both α4 and α6 
subunits and these receptors are characterised by high affinity for GABA and slow 
desensitation kinetics. Receptors containing δ subunit are located exclusively at extrasynaptic 
sites in dentate gyrus and cerebellum (Möhler, 2006, 2007). 
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2.2.4 Changes in GABAergic system and expression of GABAA receptor subunits during 
development 
As mentioned before, GABA is the major inhibitor neurotransmitter in the brain and 
activation of GABA receptors results in the hyperpolarisation of adult neuronal membrane. 
Using hippocampal slices from newborn animals up to two weeks of age it was demonstrated 
that the activation of GABA synapses in young neurons produces a depolarization instead of 
characteristic hyperpolarization (Ben-Ari et al., 1989). Afterwards, in rodents, several 
observations confirmed previous discovery that the activation of GABAA receptors produces a 
depolarization and thereby increased concentration of intracellular calcium in immature but 
not adult neurons. Depolarization was observed in a wide range of brain structures, including 
hippocampus and neocortex (Barker et al., 1998). 
This phenomena is caused by higher intracellular concentration of chloride [Cl-]i (Fig.6) 
in immature neurons compared to adult neurons by 20-40 mM. This difference is sufficient to 
shift the actions of GABA from inhibition to excitation. In contrast to immature neurons, 
reversal potential to transmembrane chloride concentration is below the resting membrane 
potential in adult neurons. In the immature neurons, reversal potential to transmembrane 
chloride concentration is above the resting membrane potential and whenever GABAA 
receptors are open chloride anions leak out the neurons and membrane becomes depolarized 
and closer to the threshold for action potential (Ben-Ari, 2002).  
The intracellular accumulation of chloride in immature neurons can be generated either 
by the early expression of an Na+-K+-2Cl- co-transporters (NKCCs) or by the delayed 
expression of K+-Cl- co-transporters (KCCs). The key feature of NKCCs is the transport 
chloride into the cell, whereas KCCs are characterized by transporting chloride out of the cell 
(Ben-Ari, 2002). 
It seems that KCC2 is seminal for the switch from GABA-mediated excitation to 
inhibition. Increase of KCC2 mRNA expression correlated with the switch of GABA actions 
(Rivera et al., 1999). Blockade of GABAA receptors prevented from the switch – the KCC2 
transporter was not expressed and GABA continued exerting depolarizing action. Thus, the 
KCC2 signal provides a feedback of GABAA receptors in which GABA itself promotes the 
shift from excitation to inhibition mediated by calcium signals. Those signals ultimately lead 
to the expression of a tranporter and consequently to reduction in [Cl-]i (Ganguly et al., 2001). 
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Fig.6 Determination of developmental changes [Cl-]i in by early expression of NKCC1 and 
late expression KCC2. a) NKCC1 expression predominates in immature neurons, in which is 
[Cl-]i relatively higher b) KCC2 expression predominates in mature neurons and [Cl-]i is 
lower. Activation of GABAA receptor generates efflux of chloride (excitation) in immature 
neurons and influx (inhibition) in adult neurons. Abcissae: VDCC – voltage-dependent 
calcium channel, CLC2 – voltage-gated chloride channel 2 (taken from Ben-Ari 2002). 
 
In addition, GABA-ergic neurons are present in proliferative, migratory and 
differentiation zones during embryonic development and GABA has been shown to positively 
stimulate several essential development functions, including neuronal migration, cell division 
and neuritic growth (Owens and Kriegstein, 2002). 
 
Along with functional switch of GABA properties, receptor subunit expression is highly 
age-related (Fig.7). The adult subunit composition of the GABAA receptors in certain brain 
regions greatly differs from that in the embryo and neonate (e.g. cortex) and some receptor 
populations persist throughout development (e.g. hippocampus) while others proceed 
postnatally almost directly to an adult form (e.g. cerebellum). One of the most striking 
features of GABAA subunit expression during brain development is widespread mRNA 
expression of the α2 and α5 subunits with early peak and consequent decline. In contrast, α1 
subunit expression increases. Expression of β1 subunit emulates that of α2 and α5 subunits, 
although at a much lower intensity. There were found no identical temporal and spatial 
patterns for two subunits expression. However, α1 and β2 expression often co-distribute while 
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α2, α3 and α5 expression often colocalize in time and region with β3 expression (Laurie et al., 
1992).  
 
 
Fig.7 Expression of the GABAA receptor subunits mRNA in selected entire regions of the 
embryonic and postnatal rat brain. Black – strong signal, dark gray – moderate signal, light 
grey – weak signal, white – very weak or undetectable signal (taken from Laurie et al., 1992). 
 
Developmental changes in the structure of GABAA receptors parallel with changes in 
function and pharmacology of these receptors. Hippocampal dentate granule cells (DGCs) and 
their GABAA receptors undergo marked changes in the pharmacological properties during the 
first 52 days of postnatal development. Functional studies demonstrate that maximal GABA-
evoked current increases with age and that furosemide and zinc inhibit GABAA receptors 
currents in young rats but not in adult rats. In parallel, structure of GABAA receptors changes 
from type BZ3 in young rats to type BZ1 in adult rats (GABAA receptors has been 
traditionally divided according to pharmacological properties – BZ types differ in affinity for 
 19
certain BZs as zolpidem),and the fraction of cells expressing loreclezole sensitive GABAA 
receptors increased with age (Kapur and McDonald, 1999). 
Changes in functional and pharmacological properties of GABAA receptors during 
development correlate with the changes in receptor subunit composition. The developmental 
changes in GABAA receptor subunits mRNA expression are associated with increase in α1 
subunit expression, maximal GABA-evoked currents, and augmentation of GABA-currents 
by zoldipem as demonstrated in DGCs.  In addition, sensitivity to zinc decreases with age 
(Brooks-Kayal et al., 2001).  
 
 
2.2.5 Consequences of BZs treatment for development of GABAA receptor 
Effects of BZs are mediated by GABAA receptors. Therefore, large number of studies 
has attempted to elucidate neurochemical changes associated with repeated BZ 
administration. 
In adult rodents, chronic BZ treatment led to decreased maximal number of 
benzodiazepine binding site in the majority of experiments. In general, regional differences 
were found, with down-regulation of benzodiazepine binding site in the cortex, hippocampus 
and amygdala; least likely to be found in cerebellum or olfactory bulb. Importantly, results 
vary among experiments most likely due to the type of  BZ, used dose and schedule of 
administration (Hutchinson et al., 1996). Studies concerning chronic BZs administration in 
adults have also reported changes in GABAA receptors subunit composition (Chen et al., 
1999; Tietz et al., 1999). 
The developing GABAergic system is highly plastic. Prenatal exposure to diazepam has 
been reported to change density of benzodiazepine binding site (Rothe and Bigl, 1989) and 
GABAA receptor structure (Roberts et al., 2001). Conversely, much less is known about long-
term effects of early postnatal treatment with BZ. Sporadic study from Raol and colleagues 
(2005) observed changes in subunit composition in adult animals exposed to diazepam early 
during development . Treatment caused a significant decrease in the mRNA expression of α1 
and α3 subunits and a significant increase in α4, α6, β3, δ and θ expression.  
 
The specific properties of GABAergic system play the important role in the immature 
brain. Changes induced in this system by BZs exposure may lead to remodelation or alteration 
of structures of functional circuity and thus participate in functional changes in the developing 
brain.  
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2.3  Behavioral consequences of early benzodiazepine administration in experimental 
studies 
It is known that children exposed to BZs pre- or postnatally experience undesirable 
effects of BZs such as poor gain weight and drowsiness. It was also suggested that exposure 
to BZs may have long-term adverse effects on neurobehavioral development, but hard data 
supporting this hypothesis are missing (Ebhard-Gran et al., 2005; Mizrahi and Clancy, 2000). 
In clinical studies, it is however difficult to separate effects of BZs from adverse effects of 
other drugs or alterations due to underlying pathologies. In addition, variability of studied 
subjects as well as social background may play important role in final outcome. Using 
experimental animals is a direct approach to address the question of whether the early BZs 
exposure without underlying pathology and additional treatment can lead to a reorganization 
of neuronal circuits, cognitive impairment, and alteration of social and/or emotional behavior. 
Most of our today knowledge about long-term effects of early BZs exposure comes from 
studies employing prenatal administration of BZs. Results of these studies suggest that 
prenatal BZs exposure could lead to behavioral deficits when tested as adults. Gai and Grimm 
(1982) found significant dose-dependent differences in a complex six-choice simultaneous 
discrimination learning task where diazepam-exposed rats made more errors and took more 
time to reach the goal. In open-field BZ rats showed longer latencies to enter field from 
starting box and lower rearing frequency (Gai and Grimm, 1982). Other studies dealing with 
prenatal BZs exposure showed various alterations including deficits in learning, active 
avoidance, conditioned place preference and exploratory behavior in various mazes, as well as 
disturbances of social behavior (Tucker, 1985; Alleva and Bignami, 1986). 
Much less data are available to demonstrate long-term behavioral consequences after 
postnatal BZs exposure. Several studies suggested that BZs administered from P1 to P21 (till 
weaning) had significant effects on social behavior during adolescence. In the home-cage 
aggression test BZ animals displayed enhanced offensive/aggressive behaviors when they 
were resident in their home-cages, but increased submissive behaviors when the BZ-exposed 
rats were intruding into another rat's territory. All these changes in behavior were dose-
dependent and highly affected by type of BZs tested (File, 1986 a, b, c). More recent 
experiment where pups received diazepam (from P2 to P21) was performed by Schroeder and 
collaborators (1997). When tested 2 months after the end of diazepam administration, animals 
displayed increased locomotor activity, reduced anxiety, but no learning or memory deficits. 
In all these studies, rats were exposed to BZs since they were born till weaning i.e. for 
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decisive part of development. Such experimental design makes very difficult to assess BZs-
induced changes of early behavior separately from direct effects of these drugs.  
 
 
2.4 Brain development and behavioral testing 
 
 
2.4.1 Brain development in rodents 
The correlation between the developmental stages of immature rodents and humans is 
indeed very complicated. At the time of birth, the rodent brain is very immature compared to 
that of human newborns. Rodents develop relatively quickly, but it still takes several weeks to 
reach fully mature stages of all biochemical, morphological and functional parameters. Using 
various molecular, biochemical, morphological, physiological, and behavioural methods, 
different studies have demonstrated the developmental time-course of individual variables. 
Therefore, even conclusions obtained in the same laboratory might vary in relation to the 
measured characteristic. For example, Adlard and colleagues (1973) claimed that a 5-day-old 
rat is an appropriate model for the human newborn in terms of brain maturation, having based 
their conclusion on the timing of the peak velocity of the accumulation of brain wet weight in 
both species. Based on the timing of the ”growth spurt” as a vulnerable-period, Dobbing 
(1970) compared human babies from the last few weeks of gestation through the first few 
months of life to rats 10 to 12 days old. In addition to biochemical parameters, the 
development of bioelectrical activity of the rat brain was studied and all the published data 
demonstrate that irregular EEG activity appears at the age of 5 to 6 days (Ellingson and Rose, 
1970) and up to P10 EEG activity is interrupted by periods of electrical silence corresponding 
to the ”tracé alternant” described by Dreyfus-Brisac and collaborators (1964) in preterm 
newborns, but are never observed in full-term human newborns. In experimental epileptology, 
rats 10 to 12 days old are generally accepted to be in a stage of maturation corresponding with 
that of human newborns or early infancy. Physiological weaning in rats occurs around P28 
and sexual maturation begins between P35 and P45 (Piacsek and Goodspeed, 1978).  
 
 
2.4.2 Behavioral studies 
Behavioral studies represent one of the possibilities how to investigate changes in the 
brain after early brain injury or exposure to a chemical agents and drugs. With proper 
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experimental design, they can be used to determine whether prenatal or postnatal drug 
exposure changes selected parameters of neurobehavioral development. Importantly, animal 
behavior studies can play essential role in assessment of possible risks created by exposures to 
doses or concentrations whose effects are below the threshold of detection of 
neuropathological methods. 
Experimental design as well as selection of behavioral tests critically affects results 
obtained in these studies. There is enormous number of behavioral tests and their well 
described modifications available to map various behavioral parameters in adult rats. 
Behavioral studies are however less frequently performed in immature animals and specific 
tests developed for individual age groups of rodents are less known (Spear, 1990). Also, 
methodology of tests specifically developed for immature individuals is not unified and 
various laboratories are usually using slightly different modifications. However, it has to be 
emphasized that even small differences in methodology (selection of age groups, duration of 
drug exposure, experimental design, etc.) can substantially change the outcome of 
developmental studies. Thus in following paragraphs, background of behavioral tests used for 
present study will be summarized. To investigate effects of early clonazepam exposure on 
animal development and behavior, we exploited the native forms of behavior and stimuli that 
can be derived from the natural environment of rats.  
 
Homing test  
Homing test exploits the strong tendency of the rat pup to maintain body contact with 
the dam and siblings (i.e. the motivation is to reach the home), which requires adequate 
sensory and motor capabilities (Bignami, 1996). This test is well-suited to study spatial 
learning in immature rodents, since remembering home localization has a high adaptive value 
in weaning and preweaning animals (Schenk, 1989). It relays primarily on olfactory cues of 
animals. Preference for familiar nest odor is detected at P7 when rats become able to turn 
towards the familiar olfactory cue (Schlumph et al.,1989). The capability to return to home 
nest is highly relate to the maturation of motor skills (Altman and Sudarshan, 1975). 
Tendency to reach the home nest is preserved till weaning (Schlumph et al.,1989). 
 
Social test 
Rats establish complex societies and they are unquenstionably social animals (Meany 
and Stewart, 1979). In rats, periadolescence is reported as a critical period for development of 
social behavior which is characterized by an increased propensity to social interaction termed 
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as social play behavior. Rats start to play around P18, playing increases with age and peaks 
around P30-P36, and declines thereafter (Burghardt, 1999). The high rewarding value of 
social play behavior (Calcagnetti and Schechter, 1992) suggests its major importance for an 
animal’s development. Social play behavior together with other social experiences in early 
life determines brain development and adult behavior (Van den Berg et al., 1999). The 
importance of early social experiences support the fact that animals may exhibit long-lasting 
behavioral changes if they are socially isolated during early life (Meany and Stewart, 1979) or 
exposed to various drugs during adolescence (Trezza and Vanderschuren, 2007). In addition 
to play related behavior, also behavior unrelated to play can be detected (for more details see 
Material and methods). These two forms of social behavior differ by their ontogenetic pattern  
because play behavior mainly occurs between weaning and puberty whereas other social 
behavior unrelated to play occur during the entire lifespan of rats (Vanderschuren et al., 
1995).  
 
Habituation test  
Habituation, defined as a response decrement following repeated or continuos 
presentation of indifferent stimuli, represents a relatively simple form of long-lasting 
behavioral plasticity and one of the most elementary type of non-associative learning 
(Cerbone and Sadile, 1994). The open field test, which is a typical all-purpose observational 
test (Bignami, 1996) is usually used to assess locomotor activity and reaction to novelty. In 
this test, habituation is defined as a decrease of activity with time of exposure (short-time 
habituation) or with number of exposures (long-time habituation). It was shown that short-
term habituation (i.e within session) can be for the first time observed at the end of the 3rd 
postnatal week, whereas long-term habituation (i.e between sessions) appears in normal rats at 
the end of the 4th week (Laviola et al., 1988).  
Animal’s performance in open field may markedly differ according to experimental 
conditions like intensity of illumination, background noise, and layout of landmarks outside 
the arena (e.g. the room furniture, the experimenter’s location) (Bignami, 1996; Bouwknecht 
et al., 2007). Therefore, the same conditions must be preserved throughout the experiment. 
In addition to assessment of locomotor activity and non-associative learning, open field 
test can be used to measure anxiety-related behavior (Bouwknecht et al., 2007).   
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Elevated plus-maze 
This paradigm is based on a competition between internal drive to explore a novel 
environment (based on the potential for rewarding outcomes) versus the internal drive to 
avoid a novel environment (based on the potential for aversive outcomes), i.e. it is based on 
the apparent natural aversion of rodents to open and high spaces of open arms and the 
tendency of rodents to explore a novel environment. This test became very popular mostly 
because it is easy to perform and all measured parameters were well characterized. This 
model was validated as an animal model of anxiety in rats and mice by many pharmacological 
and behavioral studies (Lister, 1990). In addition to studies of anxiety and screening for 
anxiolytic drugs, Itoh and colleagues (1991) reported that the elevated plus-maze can be used 
to study learning and memory. They proved that transfer latency (i.e. time necessary to move 
from the open arms to the enclosed arm) is shortened if the animal has previously experienced 
entering the open arms. During the initial exposure an animal acquires phobic avoidance of 
the open arms and retains strong memory for this threat for a certain time. Thus, with slightly 
modified experimental protocol, this model can be used to study both anxiety-like behavior 
and cognitive abilities in rodents.  
 
Morris water maze 
Morris waster maze is extensively used to investigate specific aspects of spatial memory. This 
test is based on the premise that animal evolved an optimal strategy to explore the water maze 
and escape from the water with a minimum effort - i.e. animal swims the shortest possible 
distance to escape. A submerged (hidden) platform serving as the escape from the water offers 
no local cues to guide escape behavior and therefore extra-maze visual cues are necessary for 
orientation. The latency necessary to reach a hidden platform after previous exposure, is used 
as a criterion of spatial memory. Rats are natural swimmers and they can solve the water-
maze task easily (Morris, 1984). Rats swim efficiently from P16, but they do not achieve a 
place navigation task in a water maze in the absence of any intramaze cue before P32-35 
(Schenk, 1985). The spatial navigation is highly dependent on the hippocampal integrity. 
Thus, animals cannot solve this task before maturation of hippocampal structures (Pokorný 
and Yamamoto, 1981).   
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3. Aims of the Thesis  
The goal of my thesis was to evaluate long-term effects of early clonazepam exposure 
on postnatal development and functional abilities of rats. Clonazepam was administered in 
five consecutive days starting at P7 to P11, i.e. during the critical developmental period of 
brain sprout. Based on available data we hypothesize that even short exposure to clinically 
relevant doses of clonazepam (Kubová and Mareš, 1989) during early postnatal development 
can cause long-term functional deficits. In order to test our hypothesis and to assess possible 
age-related alterations related to cognitive functions, motivation and emotionality animals will 
be tested repeatedly starting shortly after the end of administration till adulthood. Experiments 
were thus designed to study consequences of treatment not direct effects of clonazepam.  
 
Aims and scopes: 
 
1. To assess effects of early clonazepam exposure on body growth and development.  
2. To demonstrate whether early exposure to clonazepam leads to behavioral dysfunction 
related to cognitive functions, motivation and emotionality such as anxiety and fear 
3. To characterize possible effects of early clonazepam exposure on social behavior 
 
 
 
Present study is a part of project “Long-term functional consequences of early benzodiazepine 
exposure in immature rats” supported by grant No. 305/09/0846 of the Grant Agency of the 
Czech Republic 
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4. Material and methods 
 
4.1 Animals 
Experiment were performed using Wistar albino male rats (n=80). Rats derived from ten 
litters. On postnataly day 1 (PD1; birth counted as day 0) the pups were randomly fostered 
and each litter was adjusted to ten males. The animals were weaned at postnatal (P) 28. Rats 
were housed under a controlled environment (temperature 22±1 °C, humidity 50-60%, lights 
on 06.00-18.00 hours) with free access to water and food. The experiments were approved by 
the Animal Care and Use Committee of the Institute of Physiology of the Academy of 
Sciences of the Czech Republic. Animal care and experimental procedures were conducted in 
accordance with guidelines of the European Community Council directives 86/609/EEC.  
 
 
4.2 Drug and treatment 
Clonazepam (CZP; Hoffmann - Switzerland; got as a gift) was suspended in one drop of 
Tween 80 and 1ml of saline. Subsequently, this solution was diluted in such a way that 
various doses of clonazepam was administered in the same volume of 5 µl/g of body weight. 
Clonazepam was administred in three doses – 0.1 mg/kg, 0.5 mg/kg and 1.0 mg/kg 
intraperitoneally for five consecutive days starting at P7 till P11. Doses were selected 
according to our previous studies on anticonvulsive effects of clonazepam in developing 
animals (Kubová and Mareš, 1989). Control animals received a corresponding volume of 
saline.  
 
4.3 Apparatuses 
The homing test arena consisted of two transparent Plexiglas hexagonal cages (34 x 34 x 
24 cm)  connected by a small opening (diameter 4 cm). The home cage was divided in two 
equal parts by a transparent wall. The start cage was of the same dimension as the home cage. 
The pups were placed to the part of the home cage located farther from the start cage together 
with small amount of soiled bedding taken from their nest. 
The open-field arena which was used for social and habituation tests consisted of a 
black  plastic chamber (45 x 45 x 30 cm) with black floor. 
The elevated plus-maze test was conducted in the maze made from black plastic and 
consisted of two open arms and two enclosed arms elevated 50 cm above the floor (each arm 
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was 10 cm wide and 50 cm long, extending from central platform 10 x 10 cm). Two open 
arms had low walls (1 cm), while the enclosed arms had walls 50 cm high. 
The water-maze comprised of black circular pool (210 x 50 cm) filled with clear water 
(19-200C). A small transparent Plexiglas escape platform (10 cm in diameter) was placed in 
the center of an arbitrary defined quadrant of the pool (north-west). The platform was 
submerged 1.5 cm below the surface of the water and was maintained in a constant position 
throughout the experiment. Abundant extra–maze cues were available for spatial orientation. 
 
 
4.4 Procedures 
 Tests were carried out in a special room with constant temperature (22±1 °C). Low-
light conditions (35-45 lx) were used in all tests except from the water maze (100-110 lx) to 
prevent decreased behavioral activation and increased anxiety-related behavior. (Bouwknecht 
et al., 2007) Background noise was produced by a fan in digital videorecorder which 
attenuated environmental disturbances. To reduce any lingering olfactory cues, every 
apparatus was cleaned after each rat. All tests were performed between 09.00 and 15.00 
hours. 
 
Behavioral tests started 24 h after the last CZP injection and continued up to the age of 4 
months. The schedule of the whole study, i.e. timing of individual tests is summarized in 
Figure 8. Briefly, animals were exposed to the homing test four times, at the age of P12, P15, 
P18 and P23. Experiment continued with social test at P31 followed by one month long brake. 
Afterwards, animals performed habituation test for four consecutive days starting at P67. 
Animals were then tested in elevated plus maze for two times, at P74 and P75. Finally, 
animals were exposed to the water maze for five consecutive days beginning at P81.  
Body weight was assessed daily during the administration of CZP, and later on at the 
beginning of each individual experiment. 
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Fig.8 Time schedule of experiment 
 
 
Homing test (Mikulecká and Mareš, 2009; Schenk, 1989) 
Before the test pups were allowed to adapt to the new environment for 30min. 
Experimenat design was chosen according to previous study. (Mikulecká and Mareš, 2009) 
Briefly, twelve trials for P12 and 10 trials for P15, P18 and P23 rats, were used. Inter-trial 
intervals were 60s for P12 and P15 rats, 120s for P18 and 180s for P23 rats. The area of start 
cage was reduced to half for P12 rats because of decreased motor skills at this age. A correct 
homing response was considered if the pup was able to reach the home cage within 60s time 
interval. If the pup failed to enter the home cage, an experimenter gently aided him in 
direction to find the home cage.   
The five consecutive correct responses were taken as a criterion for learned homing 
response.  
Homing responses, i.e. average latency necessary to enter the home cage, and the ratio 
between correct responses and the total number of trials were analyzed. Moreover, differences 
in the same experimental group among single days were calculated. 
 
P0 P7-P11 
P12-P23 
P32 P67-P70
P74-P75 
P81-P85
 Social test
CZP 
administration   Open-Field MWM
EPM   Homing test 
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Fig.9 Homing test, a pup is just entering a small hole between the start and the home cage 
 
Social test (Corbett et al., 1991; Fraňková and Mikulecká, 1990; Vanderschuren et al., 1995) 
The social test was performed after weaning (P28) at the age of 32 days. Each animal 
was placed to the open field arena for 5 minutes in two consecutive days before testing for 
adaptation. On the day of experiment, animals were sorted into pairs. Each pair consisted two 
unrelated animals from different litters and differences in body weight between animals never 
exceeded 10%. Then animals were put individually into plexiglas cages for social isolation for 
two hours. After isolation period, pair of animals was placed into the test cage for 10 min. 
Following two behavioral categories were analyzed: 
 
 1. Behavior related to play  
- Pinning – this is defined as one of the animals lying with its dorsal surface on the floor 
of the test cage with the other animal standing over it 
- Boxing/wrestling – a group of behaviors including boxing, wrestling, and pouncing 
- Following/chasing – moving in the direction of or pursuing the test partner, who 
moves away 
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2. Behavior unrelated to play
- Social exploration – sniffing or licking any part of the body of the partner, including         
the anogenital area 
- Contanct behavior – this type includes crawling over and under the test partner and 
social grooming (chewing and licking the fur of the partner, during which the animal 
that grooms mostly places its forepaws on the back or neck of the partner) 
 
In addition, the number and the amount of time which two unfamiliar rats actively 
interact with each other in a familiar environment were measured. Therefore, the novelty of 
partner is the only stimulus which inhibits social behavior between the rats. Behavior was 
evaluated per pair of animals, which means that the behavior of an individual animal was not 
analyzed. 
 
 
 
Fig.10 Two P32 rats in the open field arena during social test 
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Habituation test – Open field  (Lister, 1990; Thiel et al., 1999) 
Animals were tested on four consecutive days starting at P67. Thirty minutes before the 
onset of testing animals were transfer into the room where the test took place. Animals were 
placed into the center of the arena and their behavior was registered for 10 min. The following 
behavioral parameters were evaluated: 
 
1. Locomotor activity – distance moved 
2. Thigmotactic scanning – time spent locomoting along the walls of the arena 
(thigmotactic area was considered as an eight centimetres wide zone along the 
walls)  
3. Centre time – time spent in the central area (central area was considered as zone 
surrounded by thigmotactic area) 
4. Rearing – frequency and duration of vertical activity (irrespective of whether it 
occurred on or off the walls) – results not included in the thesis 
5. Grooming behaviour – number and duration (considered as a complete sequence 
from paw licking and face wash through body wash and fur licking up to tail and 
genital licking and wash) – results not included in the thesis 
6. The number of faecal boli was counted 
 
Habituation of open field activity was investigated in two ways: within-session 
habituation (short-term habituation) was measured by comparing the 1st (0-5) vs 2nd (5-10) 
min interval of a given testing period. Between-session habituation (long-term habituation) 
was analyzed by comparing first day intervals vs. day four intervals.   
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Fig.11 The rat performing habituation test 
 
Elevated plus maze (Itoh et al., 1991; Lister, 1990; Mikulecká et al., 2000) 
Before the test, animals were transfere into the experimental room to acclimate for 30 
min. The animals were tested on two consecutive days starting at P74. The first day is 
considered as the acquisition session, the second day is considered as the retention session. 
Each day they were exposed to the plus maze twice for 5 min each. At the beginning of 
testing, the animal was placed at the end of the open arm with head facing the central 
platform. The following behavioral parameters were registered : 
 
1. Transfer latency – the time necessary to enter one of the enclosed arms (animals had 
to cross with all four legs an imaginary line separating the enclosed arm from the 
central platform) – expression of learning and memory 
2. Total time spent on open arms per 5-min sessions expressed as percentage of total 
time of session – expression of anxiety 
3. The number of enteries into closed arms, which expresses locomotor activity in the 
elevated plus maze 
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Fig.12 The elevated plus maze test. An animal stole from the enclosed arm and investigates 
surroundings 
 
 
Morris water maze (Kubová et al., 2004; Morris, 1984) 
The acquisition test was performed at the age of P81-P85. The rats were brought to the 
experimental room at least 30 min before experiment in order to acclimate. Each rat received 
one training session (8 swims) per day for 5 consecutive days. A trial began by placing the 
animal into 1 of 4 randomly selected sectors (north, west, south, or east; each starting point 
was used no more than 2 times per session) with the head facing towards the wall. The rat was 
allowed to swim until it found the escape platform or had swum unsuccessfully for 60 s. In 
the latter case, the rat was guided to the platform by hand and its latency in that exposure was 
recorded as 60 s. Animals were let to rest on the platform for 30-s. After each daily session 
the rats were dried with a towel and kept in a warmed cage. When their fur was dry they were 
moved back into home cages.   
To evaluate the long-term memory animals were re-tested ten and forty days after the 
end of acquisition test. Only one training session was used for this retention test.  
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The following parametres were analyzed: 
1. Escape latency – time per session which is needed for finding and climbing onto the 
submerged platform 
2. Correct/total trials – the ratio of succesful trials to the total number of given trials 
3. The long-term memory was assessed by comparing differences in escape latency of 
the last session of the acquisition test with latency from retention sessions – results 
not included in the thesis 
 
 
Fig.13 The Morris water maze test. After reaching submerged platform, the rat is resting and 
investigating surrounding area. The extra-maze visual cues (black rectangle and triangle) are 
mounted on the walls. The digital camera is mounted above the pool and serves for the 
recording of sessions. It may be exploited as an visual cue as well.  
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4.5 Evaluation 
All the tests were recorded using a digital camera (Panasonic WV-BP 330/GE, China) 
and a digital recorder (Samsung SHR-2042, Japan). Subsequently, recordings were evaluated 
offline by means of software Ethovision XT and Observer XT (Noldus Information 
Techology, Wageningen, The Netherlands). Ethovision XT is the software platform for 
automated tracking and analysis of animal movement and activity. Observer XT is the 
professional software for the collection and analysis of observational data. 
 
 
4.6 Statistical analysis 
Parameters were analyzed using SigmaStat® (SPSS Inc., Chicago, IL) software. All 
parameters were calculated with non-parametric tests. The data are expressed as mean ± SEM. 
A p-value of less than 0.05 was considered to be significant. 
Body weight was expressed as a percentage of the starting value (weight at P7 was taken 
as 100%). The relative body weight (Wrel=WP(n)/WP7 x 100) were calculated to minimize 
effect of variability. To compare weights among groups the Kruskal-Wallis analysis was used.  
Kruskal-Wallis analysis with post-hoc Dunn’s method was used in homing test, social 
test, habituation test, elevated plus maze test and Morris water maze for comparison of 
groups. 
Friedman repeated measures analysis of variance on ranks followed by Dunn’s method 
was calculated to compare differences within group in homing test and Morris water maze. 
Mann-Whitney test was used in habituation test for comparison of two days in a given 
period and within group. 
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5. Results 
 
 
5.1 Effect of clonazepam on morbidity and body weight gain 
Table 1 summarizes the numbers of animals used for present study. One pup assigned to 
CZP 0.1 mg/kg group died before the start of clonazepam administration. Mortality during 
CZP administration was very low (3 of 79 animals) compared to previously published studies 
(File, 1986 a). This can be explained by relatively low doses and short period of 
administration and also due to experienced dams used in this study. Therefore pups treated 
with clonazepam survived in spite of the lower weight gain. 
 
            
  
Drug group No. of animals in groups No. of deaths after CZP 
treatment 
No. of tested animals 
  
  Control 20 0 20   
  Clonazepam      
  0.1 mg/kg 19 2 17   
  0.5 mg/kg 20 1 19   
  1.0 mg/kg 20 0 20   
            
 
Table 1 Overview of animals assigned to experimental groups  
 
 
Before the drug administration at P7, animal weight was assessed and the average 
weight was 18 ± 0.15 g in every group and there were no differences before administration 
onset. In control group, body weight gain regularly increased between two consecutive days 
since the onset of experiment (Fig.14, 15). In CZP-exposed animals, relative body weight was 
significantly lower during drug administration in all dose groups (P<0.001). After the end of 
CZP administration, significant differences in relative body weight occurred in CZP 0.5 
mg/kg group till P18; in animals receiving CZP in a dose of 1 mg/kg body weight was lower 
till the end of study.  
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Weight curves during clonazepam treatment
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Weight curves from the onset of behavioral testing
P12 P15 P18 P23 P31
Pn
 / 
P7
 (%
)
100
200
300
400
500
600
700
Control 
0.1 mg/kg 
0.5 mg/kg 
1.0 mg/kg 
p<0.05
Age (days)  
Fig.14 Top graph - Relative body weight of rats during clonazepam treatment (P7-P11); 
Bottom graph - Relative body weight of rats from the onset of testing, i.e P12. Y-axis: relative 
body weight (body weight on the day of first injection-P7 was taken as 100%), X-axis: 
postnatal days in which body weight was measured 
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Weight curves in adulthood
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Fig.15 Relative body weight of rats in adulthood. Y-axis: relative body weight (body weight 
on the day of first injection-P7 was taken as 100%), X-axis: postnatal days in which body 
weight was measured 
 
 
5.2 Effect of clonazepam in the homing test 
In controls, homing response gradually shortened with number of tests (Fig.16). Along 
with decrease of latencies to home cage, percentage of correct responses increased (Fig.17). 
These changes were significant since P18 (Chi2=35.580, P<0.001 – homing response; 
Chi2=35.016, P<0.001 – correct responses ratio). Similarly, the improvement expressed as 
shortening of homing response and increase of correct responses was observed in all CZP- 
exposed groups. CZP 0.1 mg/kg group showed shorter latencies and higher percentage of 
correct responses since P18 (Chi2=18.459, P<0.001 and Chi2=26.064, P<0.001, respectively). 
CZP 0.5 and 1.0 mg/kg groups had significantly improved results since P15 (CZP 0.5 mg/kg : 
Chi2=34.111, P<0.001 – homing response; Chi2=36.865, P<0.001 – correct responses ratio; 
CZP 1.0 mg/kg : Chi2 41.984, P<0.001 – homing response; Chi2=39.686, P0<0.001 – correct 
responses ratio) 
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In the first test performed 24 hours after the last drug administration, homing response 
and percentage of correct responses was shorter in controls compared to animals receiving 
CZP in doses of 0.1 and 1.0 mg/kg (H=17.417, P<0.001 – homing response; H=19.585, 
P<0.001 – correct responses ratio). While in controls mean homing response was 40.5 ± 1.9 
seconds, in CZP 0.1 mg/kg group was response 49.6 ± 2.2 seconds, and in CZP 1.0 mg/kg 
group 52.6 ± 1.3 seconds. Correct response ratio was also low – 38.2 ± 6.4 % in CZP 0.1 
mg/kg and 31.3 ± 5.1 % in CZP 1.0 mg/kg, whereas in controls 66.3 ± 4.0 %. There was no 
difference in any of evaluated parameters in following tests. However, there was clear 
tendency to longer homing response as well as lower percentage of correct in both CZP 0.1 
and 1.0 mg/kg groups at P23. 10 out of 20 rats from CZP 1.0 mg/kg group had the homing 
response longer than 30 seconds (P=0.041) and 5 out of 20 rats had correct responses ratio 
equal/lower than 60% compare to control (P=0.047).  
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Fig.16 Performances in the homing test – homing response. X-axis: postnatal days in which 
homing test was performed. Asterisks mark a significant difference in comparison with 
corresponding control groups, double crosses mark a significant differences in comparison 
with P12 animals. 
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Fig.17 Performances in the homing test – ratio of correct to total responses. X-axis: postnatal 
days in which homing test was performed. Abscissa: percentage of correct responses. 
Asterisks mark a significant difference in comparison with corresponding control group, 
double crosses mark a significant differences in comparison with P12 animals. 
 
 
5.3 Effects of clonazepam in the social test 
Early CZP exposure affected behavior related to play (Fig.18). There was no difference 
in time spent with behavior related to play between controls and CZP 0.1 mg/kg group (13.6% 
vs.12.8%). Animals receiving CZP in doses of 0.5 and 1.0 mg/kg spent significantly shorter 
time playing compared to controls (2.5% and 2.8%, respectively; H=12.136, P=0.007). There 
was also tendency to decrease time spent with behavior unrelated to play (all CZP-exposed 
animals spent approximately 30% less time compare to controls). This differences however 
did not reached level of significance. 
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Typically, behavior related to play was characterized by longer duration and less 
frequent contacts between tested animals, whereas behavior unrelated to play had short 
duration and more frequent contacts. The number of contacts in both measured types of 
behavior was highest in controls. In both CZP 0.5 and 1.0 mg/kg groups frequency of contacts 
during play was lower compared to controls (H=14.795, P=0.002). CZP 0.1 mg/kg group did 
not differ from controls in this parameter. In behavior unrelated to play, number of contacts 
was significantly lower only in animals receiving the highes dose of CZP (1.0 mg/kg; 
(H=10.032, P=0.018). See Fig.19 
 
 
 
Fig.18 Performances in the social test. Graph shows duration of two observed types of 
behavior. Asterisks mark a significant difference in comparison with control group 
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Fig.19 Performances in the social test. Graph depicts the number of animal contacts during 
social test. Asterisks mark a significant difference in comparison with control group 
 
 
5.4 Effects of clonazepam in the habituation test  
During the 1st test (i.e. during the 1st exposure to the open field arena) there was no 
difference in locomotor activity between controls and CZP-exposed animals in either 5-min 
interval evaluated. (Fig.20). There was the tendency to decrease the travel distance between 
the 1st and 2nd 5-min interval, but the differences were not significant. Also, during the 4th test, 
there was no difference in travel distance between controls and CZP-exposed animals in any 
of 5-min intervals. Travel distance decreased in the 2nd 5-min interval compared to the 1st one 
in both control and CZP exposed groups. (Control – U=38.0, P<0.001; CZP 0.1 mg/kg – 
U=43.0, P=0.012; CZP 0.5 mg/kg – U=60.0, P=0.001; CZP 1.0 mg/kg – U=84.0, P=0.002).  
Comparison of travel distance during the 1st 5-min interval between the 1st and 4th tests 
showed significant increase in CZP 0.5 mg/kg group (U=227.0, P=0.041). Increase seen in 
CZP 0.1 mg/kg group was not significant. Decrease of travel distance between the 1st and 2nd 
5-min intervals occurred only in controls (U=225.0, P=0.040), but not in CZP-exposed 
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animals. Long-term habituation was impaired, whereas short-term habituation was not 
affected. 
In the 1st test, controls spent 97% of time the during the 1st 5-min interval by 
thigmotactic scanning. Data analysis showed that CZP 0.1 mg/kg group spent thigmotactic 
scanning significantly shorter time (90%) (H=13.223, P=0.004).  In the whole 4th test, there 
were no differences between controls and CZP. CZP 0.5 mg/kg group spent less time along 
the walls when compared both intervals between the 1st and 4th tests (1st 5-min – U=62.0, 
P=0.002; 2nd 5-min – U=98.0, P=0.045). See Fig.21 
 Changes in time spent in the central zone of the open field arena parallel those from 
thigmotactic scanning analysis (Fig.21). 
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Fig.20 Performances in the habituation test - travelled distance during first and fourth day. 
Asterisks mark significant differences in given periods between day one and day four. Double 
crosses mark significant differences between two periods on day four. 
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Fig.21 Performances in the habituation test – top graph: time spent with thigmotactic 
scanning; bottom graph: time spent in center. Abscissa for the bottom graph: percentage of 
time spent in the center area of open-field arena. Asterisks mark significant differences in 
given periods between day one and day four. Double crosses mark significant differences in 
comparison with control group.  
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5.5 Effects of clonazepam in the elevated plus maze test 
The transfer latency between open and closed arms (Fig. 22) did not differ between 
controls and CZP groups in any testing session. Transfer latency decreased between the 1st 
and 2nd session in both controls (U=43.0, P<0.001) and all CZP-exposed animals (CZP 0.1 
mg/kg – U=58.0, P=0.003; CZP 0.5 mg/kg – U=58.0, P<0.001; CZP 1.0 mg/kg – U=62.5, 
P<0.001)  
Early CZP exposure did not affect time spent on open arms in any session (Fig X) and 
significant decrease of time was achieved in both controls (U=80.0, P=0.002) and CZP-
exposed animals (CZP 0.1 mg/kg – U=80.0, P=0.027; CZP 0.5 mg/kg – U=85.0, P=0.006) 
except for CZP 1.0 mg/kg group in which differences did not reached level of significance 
(Fig.23). 
There was no difference in the number of entries into closed arms between controls and 
CZP-exposed animals (Fig.23) 
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Fig.22 Performances in the EPM test – transfer latency to the enclosed arm of the EPM. 
Double crosses mark significant differences between 1st and 2nd session in a given group. 
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Fig.23 Performances in the EPM test. Top graph: time spent on open arms; Bottom graph: 
number of entries into closed arms. Abscissa for the top graph: percentage of time in a session 
spent on open arm. Double crosses mark significant differences between 1st and 2nd session 
in a given group. 
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5.6 Effects of clonazepam in Morris water maze test 
All animals were able to solve this task and escape latency, i.e. time necessary to reach 
hidden platform, gradually decreased with number of session (Controls: Chi2=41.293, 
P<0.001; . CZP 0.1 mg/kg – Chi2=32.412, P<0.001; CZP 0.5 mg/kg – Chi2=64.253, P<0.001; 
CZP 1.0 mg/kg – Chi2 48.648, P<0.001). The overall analysis did not reveal any differences 
between controls and CZP groups in any sessions (Fig.24). 
The ability to find hidden platform expressed as the correct/total trial ratio was not 
affected by early CZP exposure, however, the overall analysis approached the level 
significance in all sessions and reached significance in the 4th session (H=8.380; P=0.039), 
but post-hoc comparison did not reveal any differences. (Fig.25) 
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Fig.24 Performances in the Morris water maze test - escape latency.  
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Fig.25 Performances in the Morris water maze test – ratio of correct to total trials Abscissa: 
percentage of correct trials. 
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6. Discussion 
Present data show that even short exposure to clinically relevant doses of clonazepam 
during the critical developmental period can affect anxiety-like and emotional behavior as 
well as social behavior of rats later in the life. When administered between P7-P11, CZP led 
to mild and transient changes in the homing response, age-specific test of memory and 
learning abilities, changes of anxiety-related behavior in both open field and elevated plus 
maze and subtle changes of behavior in the Morris water maze test. Early CZP exposure 
affected most markedly social behavior. In social test, specifically selected for periadolescent 
animals, early CZP exposure suppressed behavior related to play and markedly influenced 
behavior unrelated to play. 
Since their introduction, BZs have become one of the most frequently prescribed 
psychotropic drugs for their hypnotic, sedative, anxiolytic, muscle-relaxant and 
anticonvulsant properties and large therapeutic index. As highly effective tranquilizers and 
sedatives, these drugs are given to pregnant women (Heinonen, 1977) and they are also used 
in newborns (even premature), infants and children particularly for their anticonvulsant 
effects (for rev. Browne and Penry, 1973). Thus, possible unfavorable effects of early 
exposure to these drugs have been of great concern. For long time, BZs were considered to be 
relatively safe even for very young individuals, but after longer experience with these drugs 
the risk of behavioral teratogenicity became more obvious. Today, BZs are less frequently 
used in pediatric psychiatry, but they still belong to drugs of choice in treatment of childhood 
epilepsies or age-related epileptic syndromes. As antiepileptic drugs, BZs are usually used 
only for limited period of time, thus the immature brain is exposed to their effects only for 
certain developmental period (Dulac, 1994). 
Long-term drug-induced impairment is difficult to study in clinics because of 
heterogenicity of studied subjects, underlying pathologies, various genetic background etc. 
Using experimental models in healthy immature rats is a direct approach to address the 
question of whether early drug exposure without underlying pathology (e.g., brain damage, 
epilepsy) can lead to a reorganization of neuronal circuits, behavioral alterations, and 
cognitive decline. It has to be emphasized that so far published studies usually used very long 
exposure period, covering whole period since birth till weaning, or prenatal and postnatal 
period of development (Gai and Grimm 1982; Frieder et al., 1984; Schroeder et al., 1997; 
Tucker, 1985). In addition, results of these studies are also highly dependent on used 
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benzodiazepine type and dose, and selected behavioral tests/ measured parameters and 
intervals after the end of exposure (Tucker, 1985).  
For present study, behavioral tests were chosen based on previously experiences 
obtained in animals with early brain injury (status epilepticus, ischemia) or with rat pups 
subjected to antiepileptic drugs (Kubová et al., 2004; Mátéffyová et al., 2006; Mikulecká and 
Mareš, 2009; Mikulecká et al., 2000). Used doses of clonazepam are clinically relevant, i.e 
they were found to prevent the development of acquired seizures in rat pups (Kubová and 
Mareš, 1989). At the same time, the highest dose of CZP used for present study, 1 mg/kg, 
significantly affects senzorimotor functions and ultrasonic vocalization of P12 rats after single 
administration (Mikulecká et al., in preparation). Whereas anticonvulsive effects of CZP 
administered in a dose of 1 mg/kg are still detectable after 24 h (Kubová and Mareš, 1989; 
Kubová, unpublished), sedative side effects last for shorter time (Mikulecká, unpublished).  
In present study, repeated exposure to CZP in all tested doses led to decrease of body 
weight gain during administration. Animals however were gaining some weight even during 
this period. It means that even during administration of the highest dose tested animals were 
not starving or dehydrated. It has to be mentioned that BZs noticeably attenuate the ultrasonic 
vocalization in the rat pup which is considered as the distress call necessary for maternal 
retrieval (Gardner, 1985; Naito et al., 1998). Thus, CZP-exposed rat pups probably emited 
less ultrasonic signals which might result in poorer maternal care and lower weight gain. BZs 
including CZP have sedative effects in adult animals (File, 1981) and even though data for 
immature rats are very limited, single administration of CZP in tested doses is sedative also in 
developing rats (Mikulecká, unpublished). Thus, temporary growth retardation can be rather 
due to decreased ability to suck than due to lack of maternal care. Our experience speaks in 
favor of this explanation because random observations did not confirm maternal rejection or 
obvious lack of maternal attention during CZP administration. In addition, retardation in the 
growth was detected only for limited time period. Previous studies on the influence of 
malnutrition on growth of body and brain demonstrated that decrease in food supply for 
lactating dams results in retardation of general growth of pups. By the age of P21, these 
undernourished pups had reached less than 75% of the normal growth. Importantly, there was 
no difference in the wet weight of the brain between normal and undernourished rats during 
pre-weaning period and it cannot be presumed that it had a long-term effect (Dobbing et al, 
1971). Therefore, we consider it unlikely that behavioral changes detected in CZP-exposed 
rats are related to the transient growth retardation. 
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Our study revealed differences between controls and CZP-exposed animals in the 
homing tests, which is designed to study spatial learning and memory in immature rats 
(Schenk, 1989). Rats tested at P12 exhibited clear functional impairment in this test because 
they needed longer time to reach home cage and at the same time their success rate was lower 
than in controls. These alterations are probably due to the fact that CZP is not yet fully 
eliminated and some effects can still be detected even 24 h after administration as discussed 
before (Kubová and Mareš, 1989). In adult rats, acute BZs administration leads to reduction in 
spontaneous activity, but chronic treatment leads to rapid development of tolerance to 
sedative effect (File, 1985). Data on adverse effects of BZs in immature animals are sparse, 
but our previous studies suggest sedative effects also in rat pups (Kubová et al., 1999). Thus, 
failure in homing test seen 24 h after the last CZP administration can be interpreted as an 
acute adverse effect of CZP rather that cognitive impairment or functional developmental 
delay due to early CZP exposure. When tested at P23, CZP 1 mg/kg animals tended to 
prolong homing latencies and to decrease percentage of correct responses. Even though this 
tendency was not significant, number of animals exhibiting alteration in this test (i.e. homing 
latency longer than 30 s and correct response ratio equal or higher than 60%) was 
significantly higher in CZP 1 mg/kg group compared to controls. Almost half of CZP-exposed 
rats stayed for some time close to the connecting hole to the home cage before they entered to 
it. It means, that they found their way to the home cage but they did not use it immediately. 
Such deficits can be related to prior knowledge of the box that reduced the tendency to 
explore and decreased motivation to approach the nest with littermates. Decreased motivation 
as a consequence of BZs-exposure was shown previously in other experiments (Coen et al., 
1983; Fox et al., 1977). Thus, we hypothesize that mild alteration of homing reaction seen in 
CZP-exposed animals rather due to decreased motivation than impaired memory.  
Habituation is considered as an elementary type of non-associative learning manifested 
as decrease of exploratory activity with repeated exposure to an unfamiliar environment 
(Platel and Porsolt, 1982). In present study, short-term habituation was defined as decrease of 
locomotion between two 5-min intervals in the first and forth session. Long-term habituation 
was defined as a decrease of locomotion in the corresponding 5-min intervals between the 
first and the fourth testing session. Our data did not show any impairment of short-time 
habituation. In contrast, long-term habituation was impaired and CZP-exposed animals did 
not habituate. In the same CZP-exposed animals exhibited increased locomotor activity in the 
open field. The increased activity of animals exposed to BZs early during development was 
reported also by other studies. Fox and collaborators (1977) showed that mice treated with 
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BZs both pre- and postnatally (to P21 or P35) were hyperactive in T-maze. Similarly, 
consistent and lasting increase of locomotor activity was diagnosed in rats exposed to 
diazepam via lactation (P3-P18) (Frieder et al., 1984). Finally, increased activity was found in 
adult rats receiving diazepam from P2 to P21 (Schroeder et al., 1997). Our data suggest that 
persisting hyperactivity can develop even after much shorter exposure to BZs. We can 
conclude that deficit of long-term habituation can represent the impairment of non-associative 
learning, however, changes in locomotor activity can also play important role in this 
alteration.  
During the open field exposure, controls spent relatively more time in thigmotactic zone 
and they tried to avoid the center zone. Conversely, early CZP-exposed rats evidently tended 
to spent longer time in the center than controls. Ratio between time spent in the thigmotactic 
zone and center zone is considered as a rate of anxiety-related behavior in the open-field. 
Thus, our data suggest that early CZP-exposure results to anxiety reduction. Our data are in 
accordance with the reduction in anxiety in the open-field after the acute injection of 
chlordiazepoxide in the amygdala (McNamara and Skelton, 1993), which mediates fear and 
anxiety (Davis, 1992). Anxiolytic effect of BZs were repeatedly demonstrated by many 
experimental studies (Sanger, 1985). In experimental studies anxiolytic effects are most 
frequently assessed using the elevated plus maze test. In this test, administration of BZs was 
found to increase the number of entries to the open arms and time spent there (Pellow et al., 
1985; Pellow and File, 1986). In our study, early CZP-exposure did not significantly alter 
behavior of rats in EPM when tested as adults compared to controls, even though there was 
tendency to spend more time on open arms and to visit open arms more frequently than 
controls. Previous studies demonstrate long-term changes of anxiety in animals exposed to 
BZS early in the postnatal life. Schroder and collaborators (1997) reported that postnatal 
diazepam treatment (P2 to P21) reduced anxiety in animals tested 2 month later. In contrast, 
File (1987) observed that administration of diazepam in P1-P7 rats does not lead to changes of 
level of anxiety during adolescence (P35-42). Thus, effects of early BZs exposure on anxiety-
like behavior later in the life is probably related to the duration of exposure, but age at 
exposure can also play a role in later consequences. However, the role of this later parameter 
has to be further analyzed.  
The impairment of cognitive functions is considered to be the most important adverse 
effect. Cognitive deficits can severely influence day-to-day life and separate children from 
normal society. Thus, in present study several various methods were used to assess risk of 
cognitive impairment after relatively short CZP-exposure. In EPM, the transfer latency 
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employed as well-suited method for measurement of learning and memory (Itoh et al., 1990). 
Early CZP exposure did not affect this parameter in any of tested dose groups. In fact, rats 
treated with two highest doses of CZP were slightly faster than controls suggesting that 
increase of locomotor activity observed in CZP-exposed rats can change behavior in this test. 
Our data thus support results of previously published studies which did not demonstrate any 
adverse effects of early BZs exposure on cognitive abilities later in life (Fox et al., 1977; 
Frieder et al., 1984; Schroeder et al., 1997). In addition, early CZP exposure did not affect 
escape latencies in Morris water maze test. In contrast, early CZP exposure resulted to 
decrease success rate, i.e. these rats were more frequently unable to find hidden platform.  
This effect was not dose dependent, but it is possible that early exposure to CZP affects the 
escape strategy and rats start to search hidden platform later than controls. This may reflect 
rather changes in motivational or associative processes as reported previously (Coen et al., 
1983; Fox et al., 1977) than cognitive impairment.  
Changes in social behavior found in adolescent rats exposed to CZP represent the most 
important result of present study. CZP exposure affected behavior related to play in a dose-
dependent manner. Animals receiving two highest doses of CZP spent less time playing and 
also number of inter-animal contacts during play was lower. Exposure to the highest dose of 
CZP, 1mg/kg, influenced also behavior interaction unrelated to play. CZP in doses of 0.5 and 
1.0 mg/kg altered mainly the investigative components of social interaction what can be 
related to decreased motivation or to emotional changes described before. There is clear 
discrepancy between our data and results of previously published studies. File (1986 a, b) did 
not found any difference in social interactions between controls and animals exposed to CZP 
(0.5 – 1 mg/kg) between P1 and P21 in this test, whereas animals exposed to other BZs 
(lorazepam and diazepam) exhibited increased social interaction. This difference can be 
explained by differences in used methodology of evaluation (different types of behavior were 
evaluated), but different exposure time can also play a role in this differences. Thus, further 
studies are necessary to identify effects of early BZ-exposure on social behavior and its 
development. 
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7. Conclusions 
Present study demonstrates that daily administration of clonazepam (0.1 – 1 mg/kg; 
CZP) from P7 to P11 has only minimal impact on normal body growth and it also did not 
increase mortality of experimental animals. On the other hand, we found both short- and long-
term functional changes in animals with early BZs experience. BZs exposure altered social 
play behavior in juvenile rats. In contrast, memory and learning abilities were not affected. 
Except social interactions, behavioral changes did not exhibit clear dependence on the used 
dose. In parallel experiments with PTZ, both seizure susceptibility and severity of seizures 
were significantly higher up to 6 days after the last administration of CZP (1mg/kg). Thus, we 
expect that even short-term administration of benzodiazepines which does not alter 
significantly body growth and normal maturation can affect transiently and/or permanently 
specific brain functions. We hypothesize that functional changes seen in animals exposed to 
BZS early in the life can be related to the re-modeling of underlying functional circuitries. 
Data obtained in this thesis will extend common knowledge about risks of early BZs 
treatment and mechanisms participating in functional changes.  
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